Back to Journals » Journal of Asthma and Allergy » Volume 16

Anaphylaxis Following Contrast-Enhanced CT with Iodixanol: A Case Report and Literature Review [Corrigendum]

Authors Qiu L, Cui Q, Gong X, Zhou H

Received 28 February 2023

Accepted for publication 28 February 2023

Published 2 March 2023 Volume 2023:16 Pages 239—240

DOI https://doi.org/10.2147/JAA.S410451



Qiu L, Cui Q, Gong X, Zhou H. J Asthma Allergy. 2023;16:195-200.

The authors have advised that the manufacturer for iodixanol on page 196, Case Report section, second paragraph, line 3, should be changed from Visipaque 320, GE Healthcare, Cork, Ireland to Jiangsu Hengrui Medicine Co., Ltd

The sentence should read from

“For this procedure, the patient received a total of 70 mL of iodixanol intravenously (Visipaque 320, GE Healthcare, Cork, Ireland).”

to

“For this procedure, the patient received a total of 70 mL of iodixanol intravenously (Jiangsu Hengrui Medicine Co., Ltd).”

The authors apologize for this error.


Read the original article


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.